Back to Qube Research & Technologies Ltd Qube Research & Technologies Ltd

TARATARA
10 quarters

Position history for Qube Research & Technologies LtdQube Research & Technologies Ltd's holdings in PROTARA THERAPEUTICS INC

Yes. Qube Research & Technologies holds 1,045,516 shares of TARA (Protara Therapeutics), worth $4M, as of its Q2 2026 13F filing. It increased the position from 177,004 shares in Q1 2026. Qube Research & Technologies has held TARA since Q4 2025, across 3 quarterly 13F filings.

Current Value

$4M

Current Shares

1M

Total Value Change

+$4M

Total Shares Change

+1M

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2026-Q2
Latest
Increased
1M
+490.7%
$4M0.0%$3.82
43
2026-Q1
Increased
177,004
+54.8%
$922,1910.0%$5.21
35
2025-Q4
New
114,331
-
$609,3840.0%$5.33
34
2025-Q2
Exited
0
-100.0%
$00.0%$3.03
0
2025-Q1
New
61,917
-
$263,7660.0%$4.26
32
2024-Q3
Exited
0
-100.0%
$00.0%$1.83
0
2024-Q2
Unchanged
2
0.0%
$40.0%$2.08
0
2024-Q1
Unchanged
2
0.0%
$80.0%$4.01
0
2023-Q4
Unchanged
2
0.0%
$40.0%$1.88
0
2023-Q3
New
2
-
$30.0%$1.67
17

Other major holders of TARA: Janus Henderson Group Ltd., RA CAPITAL MANAGEMENT, L.P., Jupiter Topco LLC

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used